cTnI /CK-MB/Myo Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of cTnI /CK-MB/Myo (Cardiac Troponin I/ Creatine Kinase Isozyme/Myoglobin ) in human serum . cTnI is used as an aid in the diagnosis of myocardial injury such as Acute Myocardial Infarction (AMI),Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS). CK-MB is an important indicator for the diagnosis of acute myocardial infarction (AMI), which is secreted into the blood in large quantities during the attack.CK-MB began to rise 3-6h when AMI symptoms occur, and reached the peak value after 12-24h. If there were no complications, the level of CK-MB in the blood would be restored to the normal level after 3d; if there were complications, the level of CK-MB in the blood would remain high and not decrease. If AMI occurs again, the CK-MB that has declined will rise again. CK-MB measurement can also be used as a non-invasive evaluation index for myocardial reperfusion after thrombolytic therapy. Myo can be used as the most sensitive index in the early diagnosis of acute myocardial infarction (AMI).
Input your search keywords and press Enter.
Product Inquiry Form